Published in:
01-12-2005
Successful Use of Recombinant Factor VIIa (NovoSeven) During Cardiac Surgery in a Pediatric Patient with Glanzmann Thrombasthenia
Authors:
B.T. Yilmaz, B. Alioglu, E. Ozyurek, H.T. Akay, S. Mercan, N. Ozbek
Published in:
Pediatric Cardiology
|
Issue 6/2005
Login to get access
Abstract
Glanzmann thrombasthenia is a rare, hereditary, congenital disorder of platelet function characterized by inappropriate bleeding that is difficult to control. Recombinant activated factor VII (rFVIIa) is a new treatment that is used to stop bleeding and provide surgical support for these patients. This report describes the use of rFVIIa to prevent serious bleeding during and after open-heart surgery in a child with Glanzmann thrombasthenia.